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Abstract
Background
The influence of genetic ancestry on Trypanosoma cruzi infection and Chagas disease out-
comes is unknown.
Methodology/Principal Findings
We used 370,539 Single Nucleotide Polymorphisms (SNPs) to examine the association
between individual proportions of African, European and Native American genomic ances-
try with T. cruzi infection and related outcomes in 1,341 participants (aged 60 years) of
the Bambui (Brazil) population-based cohort study of aging. Potential confounding variables
included sociodemographic characteristics and an array of health measures. The preva-
lence of T. cruzi infection was 37.5% and 56.3% of those infected had a major ECG abnor-
mality. Baseline T. cruzi infection was correlated with higher levels of African and Native
American ancestry, which in turn were strongly associated with poor socioeconomic circum-
stances. Cardiomyopathy in infected persons was not significantly associated with African
or Native American ancestry levels. Infected persons with a major ECG abnormality were at
increased risk of 15-year mortality relative to their counterparts with no such abnormalities
(adjusted hazard ratio = 1.80; 95% 1.41, 2.32). African and Native American ancestry levels
had no significant effect modifying this association.
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Conclusions/Significance
Our findings indicate that African and Native American ancestry have no influence on the
presence of major ECG abnormalities and had no influence on the ability of an ECG abnor-
mality to predict mortality in older people infected with T. cruzi. In contrast, our results
revealed a strong and independent association between prevalent T. cruzi infection and
higher levels of African and Native American ancestry. Whether this association is a conse-
quence of genetic background or differential exposure to infection remains to be
determined.
Author Summary
Chagas disease (ChD), which is caused by the protozoan Trypanosoma cruzi, affects
approximately 8 million people worldwide. ChD is known as a neglected tropical disease.
The disease is endemic in South and Central American countries, and is an emerging issue
in North America and Europe. This study examined, for the first time, the association
between genomic ancestry and T. cruzi infection, Chagasic cardiomyopathy and its ability
to predict long term mortality. Our results show that persons with higher levels of African
and Native American ancestries (and the reverse for European ancestry) are more likely to
be infected with T. cruzi. However, genomic ancestry had no effect on either Chagasic car-
diomyopathy or on its ability to predict mortality. Whether the association between T.
cruzi infection and genomic ancestry is a consequence of genetic susceptibility or differen-
tial exposure to infection due to poor socioeconomic circumstances over the life course,
remains to be determined.
Introduction
Chagas disease (ChD), which is caused by the protozoan Trypanosoma cruzi, affects approxi-
mately 5.7 million people in 21 Latin American countries [1]. ChD is known as a neglected
tropical disease and is an emerging issue in North America and Europe [2–5]. ChD is autoch-
thonous in South and Central America but T. cruzi infection has spread to other regions of the
world primarily due to immigration of infected persons [2], although there has been evidence
of some locally-occurring infections in the United States [3]. Currently, at least 300,000 persons
with T. cruzi infection live in the US [4] and at least 80,000 in Europe [5]. The disease is costly
to individuals and society with estimates of over USD 100 million spent on treatments and
over USD 800 million in lost productivity each year [6]. Up to one third of those infected with
ChD may develop chronic heart abnormalities and other complications of which Chagas car-
diomyopathy is the most severe and life-threatening form [7]. The presence of major electro-
cardiogram (ECG) abnormalities (a diagnostic measure of Chagas cardiomyopathy) doubles
the risk for mortality in T. cruzi-infected elderly populations [8].
The influence of African and/or Native American ancestry on T. cruzi infection and/or
ChD outcomes is unknown. The existence of an association is plausible for at least two rea-
sons: first, familial aggregation of T. cruzi seropositivity and ECG abnormalities have been
found in highly endemic areas, suggesting that genetic variation may play a role in suscepti-
bility to infection as well as disease progression [9,10]; second, an earlier publication, using
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ethnoracial self-classification, reported greater prevalence of ECG abnormalities among
Black middle-aged adults relative to their White counterparts [11].
Latin America is one of the most ethnoracially heterogeneous regions of the world [12], and
Brazil is the largest and the most populous ChD endemic country in the region. The current
Brazilian population’s genetic makeup is the product of admixture between Amerindians,
Europeans colonizers or immigrants, and African slaves [13]. Brazil received nearly 4 million
slaves from Africa, about seven times more than the United States [14]. Thus, the Brazilian
population provides an opportunity to assess the relationship between T. cruzi infection and its
complications with genetic ancestry in admixed populations.
The Bambui-Epigen Cohort Study of Aging is conducted in a well-defined population of
older Brazilian adults living in a formerly ChD endemic area [15]. We examined for the first
time the association between genome-wide proportions of genomic ancestry with T. cruzi
infection and cardiomyopathy, taking into account an array of socioeconomic and health indi-
cators that could confound such an association. Additionally, we examined whether genomic
ancestry affects the prognostic value of major ECG abnormalities for 15-year mortality in T.
cruzi-infected individuals.
Methods
Study design and population
The Bambui cohort study of aging is ongoing in Bambuí, a city of approximately 15,000 inhabi-
tants in the state of Minas Gerais in Southeast Brazil, which is one of the oldest known endemic
areas for ChD [16–18]. Detailed information on this cohort can be found elsewhere [15].
Briefly, the population eligible for the cohort consisted of all residents aged 60 years and over
on 1 January 1997 (92% of the 1,742 inhabitants in this age group participated). Most partici-
pants had some degree of admixture between African, European and Native American geno-
mic ancestry [19,20].
T. cruzi infection
T. cruzi infection status was assessed by means of three different assays performed concur-
rently: a hemagglutination assay (Biolab Merieux SA, Rio de Janeiro, Brazil) and two enzyme-
linked immunosorbent assays (Abbott Laboratories, Inc., North Chicago, Illinois; and Wiener
Laboratories, Rosario, Argentina). Infection with T. cruzi was defined by seropositivity in all of
the three examinations; seventeen persons had discordant results among the assays and were
excluded from the analysis. As far as we could determine, none of the cohort participants had a
history of use of antitrypanosomal medications, and none of the seropositive subjects reported
such treatment over the ensuing decade during annual follow-up visits. Thus, the use of anti-
trypanosomal therapy was not considered in the present analysis. In addition, no cohort partic-
ipant had received a cardiac transplant.
Electrocardiogram
At the baseline examination, a digitally recorded 12-lead ECG (Hewlett Packard MI700A)
reading was obtained at rest. ECGs were analyzed at the ECG Reading Center (EPICARE,
Wake Forest University) and classified using the Minnesota Code (MC) criteria [21,22]. Major
ECG abnormalities were defined by the presence of at least one of the following: old (MC 1.1.x
or 1.2.x) or possible myocardial infarction (1.3.x and 4.1.x, 4.2, 5.1, or 5.2), complete intraven-
tricular blocks (MC 7.1, 7.2, 7.4, or 7.8), frequent supraventricular or ventricular premature
beats (MC 8.1.x, except 8.1.4), major isolated ST segment or T-wave abnormalities (MC 4.1.x,
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4.2, 5.1 or 5.2), atrial fibrillation or flutter or supraventricular tachycardia (MC 8.3.x.or 8.4.2),
other major arrhythmias (MC 8.2.x, except 8.2.1), major atrioventricular conduction abnor-
malities or pacemaker use (MC 6.1, 6.2.x, 6.4, 6.8, 8.6.1 or 8.6.2), major QTi prolongation
(>115%) and left ventricular hypertrophy (LVH) (MC 3.1 together with [4.1.x, 4.2, 5.1, or
5.2]). Further details can be seen elsewhere [8].
Genetic and ancestry analyses
Cohort participants were genotyped with the Omni 2.5M array (Illumina, San Diego, Califor-
nia) [13]. We performed ancestry inferences using the model-based method [23], implemented
in the Admixture software. First, we used 370,539 SNPs to estimate for each individual African,
European and Native American tri-hybrid ancestry proportions, using 266 African, 262 Euro-
pean and 93 Native American individuals from public datasets as parental populations [13].
Further, we inferred a kinship coefficient for each pair of individuals, using the software Reap
[24], conditioning on tri-hybrid individual admixture proportions. We used complex networks
to identify families from the matrix of pair-wise kinship coefficients [13]. In this approach,
pairs of individuals (i.e. families) are related if they have a kinship coefficient>0.1 (first and
second-degree relatives). Given that Brazilians with African ancestry generally have a high pro-
portion of East African genetic markers (as opposed to markers of West African origin), rela-
tive to African Americans and those from the Caribbean [13,25,26], we used 331,790 SNPs and
the reference dataset “U” [13] to further divide total African ancestry into its two components:
a Western-African/non Bantu and an Eastern African/Bantu, hereafter called Western African
and Eastern African, respectively. The fact that many Bambuí residents are related could affect
high-resolution inferences of biogeographic ancestry (such as West- and East-African) with
the Admixture software. To overcome this limitation, we performed separate Admixture runs
to infer West- and East- African ancestry components, avoiding the presence of related indi-
viduals in the same run. Further details on how genetic and ancestry analyses of the Bambui
cohort population were performed can be found elsewhere [13,27].
Mortality
Deaths that occurred between study enrollment in 1997 and December 31, 2011, were included
in the present analysis. Deaths were reported by next of kin during the annual follow-up inter-
view and verified through the Brazilian mortality information system. Death certificates were
obtained for 95.7% of the participants who died. Deaths from any cause were considered in this
analysis.
Other variables
Potential confounding variables included baseline sociodemographic characteristics (age, sex,
schooling, household income and father’s occupation) and health measures (current smoking,
hypertension, diabetes, coronary heart disease, C-reactive protein and non-HDL cholesterol
level). We categorized schooling into incomplete primary school (<4 years) and complete pri-
mary and higher (4 years and more). We categorized monthly household income per capita
into equal or superior to the median value (median = 1.5 Brazilian minimum wages or USD
180 in 1997). Occupation of the study participant’s father (as informed by cohort members)
was categorized into urban workers, landowners, manual rural workers and unknown. Current
smokers were persons who had smoked at least 100 cigarettes during their lifetime and who
still smoke. Body mass index (BMI) was defined as weight (in kg) divided by height (in meters)
squared. Hypertension was defined by mean (two out of three measures) systolic blood pres-
sure of140 mmHg and/or diastolic pressure of90 mmHg and/or treatment [28]. Diabetes
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mellitus was defined by fasting blood glucose126mg/dL and/or treatment [29]. Coronary
heart disease was defined by prior medical diagnosis of myocardial infarction and/or symp-
toms of angina pectoris [30]. High sensitivity C-Reactive Protein was measured by the CRP
immunonephelometric method (BNII, Dade Behring, Marburg, Germany). Blood fasting glu-
cose and cholesterol were determined by using standard enzymatic methods (Merck, Darm-
stadt, Germany). Non-HDL cholesterol was defined by total cholesterol level minus HDL
cholesterol.
Statistical analysis
Unadjusted analyses were based on Pearson´s chi square, oneway ANOVA and Kruskall Wallis
tests to examine differences across frequencies, means and medians, respectively. Individual
proportions of genomic ancestries were expressed as medians or divided into quintiles.
Prevalence ratios (PR) estimated by multivariable Poisson regression [31] were computed to
examine associations between (i) genomic ancestry in quintiles and T. cruzi infection and (ii)
genome ancestry in quintiles and major ECG abnormality among persons infected with T.
cruzi. Further, we used Cox proportional hazard models to implement an analysis restricted to
persons infected with T. cruzi to assess the influence of each category of genomic ancestry on
the risk of major ECG abnormalities and subsequent mortality.
The above-mentioned statistical analyses were based on two models. First, prevalence and
hazard ratios were adjusted for age (continuous), sex, smoking, hypertension, diabetes, coro-
nary heart disease (all dichotomous variables) plus body mass index, log-transformed C-reac-
tive protein and non-HDL cholesterol (as continuous measures). We then added schooling,
monthly household income per capita, and father’s occupation to the previous models. Because
913 participants were first- or second-degree relatives, and excluding them would lead to loss
of power and possible selection bias, we kept all related individuals in our analyses and used
robust variance estimators in multivariate models to correct results for clustering by family
structure. Finally, we examined separately the significance of the effect of multiplicative inter-
actions between sex and genomic ancestry on each outcome by means of cross-product terms
in Poisson and Cox proportional hazards regression models, respectively. Since there was no
evidence of interaction with sex, the analyses were carried out for both men and women with
sex included as a covariate.
Separate analyses were performed for African, Native American and European genomic
ancestries and further for Western African sub continental ancestry. Statistical analyses were
conducted using STATA 13.0 statistical software (Stata Corporation, College Station).
Ethics assessment
The Bambui cohort study of aging was approved by the Institutional Review Board of the
Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Genotyping was approved by Brazil’s
national research ethics committee, as part of the Epigen-Brazil protocol (CONEP, resolution
15895). Written informed consent was obtained from all participants at baseline and at all fol-
low-up interviews.
Results
Of the 1,606 baseline cohort participants, 1,343 had complete information for all study vari-
ables and were included in the current analysis. As shown in Table 1, the prevalence of T. cruzi
infection was 37.6% (n = 505). At baseline, the mean age of participants was 68.8 years, 61.2%
were women, and low schooling level (<4 years) largely predominated (64.1%). The median
proportions of African, Native American and European genomic ancestries were 9.6%, 5.4%
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and 83.8%, respectively. The median proportion of Western African sub-continental ancestry
relative to total African ancestry was 63.9% (complementarily, the corresponding value for
Eastern African ancestry was 36.1%). T. cruzi infected participants had significantly higher
median individual proportions of African and Native American ancestries and significantly
lower median European genomic ancestry. Other baseline characteristics of the study partici-
pants, by T. cruzi infection status, are presented in Table 1.
Table 2 presents median individual proportions of African, Native American and European
genomic ancestries by baseline characteristics. Median African and Native American genomic
ancestries were significantly higher (and European ancestry was significantly lower) among
those with lower schooling and income levels, those whose fathers were manual workers or had
an unknown occupation, as well as those with any major ECG abnormality or previous coro-
nary heart disease. Median African ancestry was lower in those aged 69 years and over and in
those with BMI under 25 kg/m2. No significant associations with genomic ancestry were found
for other study variables.
Associations between the different genomic ancestries and T. cruzi infection are shown in
Table 3. There was a graded positive univariate association between T. cruzi infection with the
Table 1. Selected baseline characteristics of study participants, and by Trypanosoma cruzi infection (The Bambui Cohort Study of Ageing).
Characteristics Total Infection
(n = 1343) Yes (n = 505) No (n = 838)
Age in years, mean (SD) 68.8 (7.0) 69.2 (6.9) 68.6 (7.0)
Female sex, % 61.2 67.9 57.2a
< 4 years of schooling 64.1 84.8 51.7b
Monthly household income per capita < 180 USD 46.9 52.7 43.4b
Father’s occupation, %
Urban 11.4 4.2 15.8a
Rural: landowner 25.4 16.5 30.8
Rural: manual worker 52.4 67.6 43.3
Unknown 10.7 11.7 10.1
Current smokers, % 17.7 16.8 18.3
Any major ECG abnormality, % 41.0 56.4 31.7a
Body mass index in kg/m2, mean (SD) 25.1 (4.9) 24.4 (5.1) 25.6 (4.8)b
Hypertension, % 61.3 60.4 61.8
Diabetes, % 14.6 10.7 17.0b
Coronary heart disease, % 13.1 17.6 10.4b
High sensitivity C-reactive protein in mg/L, median (IQR) 3.17 (4.93) 3.08 (4.92) 3.25 (4.94)
Non-HDL cholesterol in mg/dL, mean (SD) 185.0 (50.0) 184.0 (51.2) 185.6 (51.2)
African genomic ancestry, median (IQR) 9.6 (12.7) 12.8 (15.2) 8.4 (10.5)a
Native American genomic ancestry, median (IQR) 5.4 (5.6) 7.1 (5.9) 4.6 (4.8)a
European genomic ancestry, median (IQR) 83.8 (16.9) 78.6 (19.4) 86.1 (15.2)a
Proportion of sub continental ancestry relative to total African genomic ancestry
Western African, median (IQR) 63.9 (28.9) 65.0 (23.5) 62.5 (31.9)
Eastern African, median (IQR) 36.1 (28.9) 35.1 (23.5) 37.5 (31.9)
SD, standard deviation; ECG, electrocardiogram; IQR, interquartile range; HDL, high-density lipoprotein cholesterol.
ap<0.001, Pearson´s chi square, one way ANOVA or Kruskall Wallis tests for differences between frequencies, means and medians, respectively.
bp<0.01, Pearson´s chi square, one way ANOVA or Kruskall Wallis tests for differences between frequencies, means and medians, respectively.
doi:10.1371/journal.pntd.0004724.t001
Genomic Ancestry and Chagas Disease
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004724 May 16, 2016 6 / 14
proportion of African and Native American ancestry, and a graded negative relationship with a
greater proportion of European ancestry (p<0.001 for all). After adjustments for age, sex and
health measures, persons at the intermediate and highest quintiles of African and Native Ameri-
can ancestry were significantly more likely to be infected with T. cruzi relative to their counter-
parts in the lowest quintiles. After further adjustments for socioeconomic indicators (schooling,
income and father’s occupation) these associations were attenuated, but remained largely signifi-
cant (PR = 1.38; 95% CI 1.07, 1.79 and PR = 1.74; 95% CI 1.37, 2.35 for those at the intermediate
and highest quintiles of African ancestry, respectively, and PR = 1.54; 95% CI 1.19, 1.99 for those
at the highest quintile of Native American ancestry). The opposite trend was found for European
ancestry (PR = 0.73; 95% CI 0.63, 0.85 and PR = 0.54; 95%CI 0.41, 0.70, respectively).
Among those infected, 56.4% had at least one major ECG abnormality (31.7% among the
non-infected). As shown in Table 4, in the bivariate analysis, a major ECG abnormality among
infected persons was not found to be significantly (p>0.05) associated with African, Native
American or European ancestry levels. This absence of association remained in analyses
Table 2. Baseline characteristics of study participants significantly associated with African, Native American and/or European genomic ancestry
(The Bambui Cohort Study of Ageing).
Characteristics African Native American European
Median (IQR) Median (IQR) Median (IQR)
Age in years
<69 10.3 (13.2) 3.5 (4.7) 83.1 (17.6)
> = 69 (above the mean) 9.0 (11.8)a 3.2 (4.2) 84.9 (16.8)b
Schooling in years
> = 4 6.7 (8.7) 2.5 (3.4) 89.0 (13.0)
<4 11.5 (13.2)b 4.0 (5.0)b 80.6 (17.1)b
Monthly household income per capita
< 180 USD (below the median) 11.0 (13.5) 3.9 (4.7) 81.5 (18.3)
> = 180 USD 8.9 (10.9)b 2.9 (4.2)b 85.3 (16.3)b
Father’s occupation, %
Urban 7.6 (9.2)b 2.5 (3.8)b 87.7 (14.3)b
Rural: landowner 6.6 (8.7) 2.7 (3.4) 88.7 (12.7)
Rural: manual worker 11.5 (13.4) 4.0 (5.1) 80.7 (16.9)
Unknown 11.8 (17.4) 3.9 (5.0) 80.0 (21.7)
Any major ECG abnormality
No 9.2 (11.8) 3.2 (4.5) 84.7 (16.9)
Yes 10.3 (13.3)c 3.5 (4.5)c 82.5 (17.6)a
Body mass index in kg/m 2
< 25 10.0 (13.2) 3.5 (4.6) 83.4 (18.4)
> = 25 9.4 (11.6)c 3.2 (4.4) 84.4 (16.2)c
Coronary heart disease
No 9.4 (12.3) 3.3 (4.4) 84.2 (16.7)
Yes 10.7 (13.6)c 3.9 (5.2)c 81.1 (17.6)c
IQR, interquartile range; ECG, electrocardiogram.
ap<0.01, Kruskall Wallis tests for differences between medians.
bp<0.001, Kruskall Wallis tests for differences between medians.
cp<0.05, Kruskall Wallis tests for differences between medians.
doi:10.1371/journal.pntd.0004724.t002
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adjusted for age, sex and health measures, as well as in analyses further adjusted for socioeco-
nomic indicators.
Over a 15 year follow-up period, 683 participants died and 109 (8.1%) were lost to follow-
up, leading to 14,680 person-years (pyrs) of observations (5,251 pyrs among the infected). The
death rate was 46.4 per 1,000 pyrs (56.2 and 40.9 per 1,000 pyrs among T. cruzi infected and
non-infected, respectively). As shown in Table 5, persons infected with T. cruzi with any major
ECG abnormality were at significantly increased risk of death, compared to their counterparts
with no such abnormalities, independent of age, sex and other health measures (HR = 1.83;
95% CI 1.44, 2.34). Further adjustments for socioeconomic indicators had little impact on this
association (HR = 1.78; 95% CI 1.39, 2.28). The association was consistent across different lev-
els of African, Native American and European genomic ancestries. We found no evidence of
statistically significant multiplicative interactions between African, Native American and Euro-
pean genome ancestry levels and major ECG abnormalities on mortality (p>0.05 for all).
As shown in Table 6, a statistically significant association between Western African propor-
tion and T. cruzi infection was found in bivariate analysis, but the association lost significance
after adjustments for socio demographic characteristics and health measures. Furthermore, we
did not find any evidence of an association between the above mentioned ancestry levels and
the presence of major ECG abnormalities among people infected with T. cruzi in either univari-
ate or multivariate analyses (p>0.05 for both). Finally, as previous observed for global African
ancestry, levels of Western African ancestry did not modify the association between a major
ECG abnormality and subsequent mortality among infected subjects (p value for interactions
>0.05).
Table 3. Association between individual proportion of African, Native American and European genomic ancestry levels with Trypanosoma cruzi
infection (The Bambui-Epigen Cohort Study of Aging).
Genome ancestry in
quintiles
Number % Infected with
T. cruzi
PR (95% CI) adjusted for age, sex
and health measuresa
PR (95% CI) adjusted for age, sex, health measuresa
and socioeconomic indicatorsb
African
Lowest (<4.2%) 269 21.2 1.0 1.0
2nd-4th (4.2%-
19.9%)
808 37.4 1.73 (1.32, 2.27) 1.38 (1.07–1,79)
Highest (20%) 266 54.9 2.52 (1.90, 3.35) 1.74 (1.37–2.35)
p<0.001
Native American
Lowest (<2.3%) 272 22.8 1.0 1.0
2nd-4th (2.3%-9.3%) 807 37.3 1.63 (1.26, 2.10) 1.22 (0.96, 1.55)
Highest (9.4%) 264 53.8 2.37 (1.81, 3.10) 1.54 (1.19, 1.99)
p<0.001
European
Lowest (<71%) 269 57.3 1.0 1.0
2nd-4th (71%-92.7%) 806 36.7 0.65 (0.55–0.76) 0.73 (0.63, 0.85)
Highest (93%) 268 20.5 0.36 (0.27–0.48) 0.54 (0.41, 0.70)
p<0.001
PR (95% CI), prevalence ratio (95% confidence interval) estimated by Poisson regression; p, p value—Pearson´s chi square test.
aSmoking, body mass index, hypertension, diabetes, coronary heart disease, log high sensitivity C-reactive protein and non-HDL cholesterol plus cluster
in family.
bSchooling level, monthly household income per capita and father’s occupation.
doi:10.1371/journal.pntd.0004724.t003
Genomic Ancestry and Chagas Disease
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Discussion
The key findings of the current study are: first, T. cruzi infection was strongly correlated with
both African and Native American ancestry—and conversely showed a negative correlation
with European ancestry—and this association had a graded effect; second, cardiomyopathy in
infected persons was not associated with either African or Native American or European ances-
try levels; third, genomic ancestry had no significant effect modification on the prognostic
value of major ECG abnormalities for mortality in T. cruzi infected older adults; fourth, West-
ern African sub continental origin was not associated with either T. cruzi infection or related
outcomes. The above-mentioned findings were independent of an array of sociodemographic
and biological confounders.
The association between T. cruzi infection and higher levels of African and Native American
ancestry may result from genetic influence on susceptibility and/or greater exposure to infec-
tion in these groups during the life course. Our study population was born before 1940, and
this cohort has experienced dramatic political and social changes during their lifetimes. Brazil
has transitioned from a low-income, primarily rural country in the mid-1950s, to one of the
largest economies in the world, with 84% of the population living in urban areas by 2010
[32,33]. Chagas disease is related to poor socio-economic circumstances, mostly in early life. In
endemic areas, the main source of infection is a bloodsucking triatomine insect that colonizes
poor households. Most individuals in these areas acquire the infection before they reach 20
years of age [34]. Further, ethnoracial disparities in Brazil are remarkable. Persons of African
origin are more likely to have lower income and education, to experience race-based
Table 4. Association between individual proportion of African, Native American and European genomic ancestry levels with anymajor electrocar-
diogram abnormalities among infected with Trypanosoma cruzi (The Bambui-Epigen Cohort Study of Aging).
Genomic ancestry
in quintiles
Number % with any major ECG
abnormality
PR (95% CI) adjusted for age,
sex and health measuresa
PR (95% CI) adjusted for age, sex, health
measuresa and socioeconomic indicatorsb
African
Lowest (<4.2%) 57 57.9 1.0 1.0
2nd-4th (4.2%-
19.9%)
302 57.0 1.00 (0.79,1.25) 0.99 (0.78, 1.24)
Highest (20%) 146 54.8 0.96 (0.73, 1.27) 0.96 (0.73, 1.26)
p = 0.886
Native American
Lowest (<2.3%) 62 56.5 1.0 1.0
2nd-4th (2.3%-9.3%) 301 57.1 1.02 (0.71, 1.97) 1.01 (0.69, 1.48)
Highest (9.4%) 142 54.9 0.99 (0.66, 1.48) 0.98 (0.64, 1.49)
p = 0.908
European
Lowest (<71%) 154 52.6 1.0 1.0
2nd-4th (71%-
92.7%)
294 58.1 1.11 (0.91, 1.36) 1.11 (0.91, 1.35)
Highest (93%) 55 58.2 1.04 (0.77, 1.39) 1.05 (0.79, 1.40)
p = 0.515
ECG, electrocardiogram; PR (95% CI), prevalence ratio (95% confidence interval) estimated by Poisson regression; p, p value—Pearson´s chi square
test.
aSmoking, body mass index, hypertension, diabetes, coronary heart disease, log high sensitivity C-reactive protein and non-HDL cholesterol plus cluster
in family.
bSchooling level, monthly household income per capita and father’s occupation.
doi:10.1371/journal.pntd.0004724.t004
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Table 5. Hazard ratio for 15-year mortality by the presence of any major electrocardiogram abnormalities among infected with Trypanosoma cruzi
and stratified by individual proportion of African, Native American and European ancestry levels (The Bambui-Epigen Cohort Study of Aging).
ECG abnormality and
ancestry level in quintiles
No. Deaths (Death rate
per 1,000 pyrs)
HR (95% CI) adjusted for age,
sex and health measuresa
HR (95% CI) adjusted for age, sex, health
measuresa and socioeconomic indicatorsb
All
No ECG abnormality 100 (38.2) 1.0 1.0
ECG abnormality 97 (74.8) 1.83 (1.44, 2.34) 1.78 (1.39, 2.28)
African ancestry
No ECG abnormality 100 (38.2) 1.0 1.0
ECG abnormality
Lowest (<4.2%) 20 (59.3) 1.25 (0.78, 2.02) 1.13 (0.70, 1.84)
2nd-4th (4.2%-19.9%) 122 (77.7) 1.93 (1.47, 2.54) 1.90 (1.43, 2.51)
Highest (20%) 55 (75.5) 1.75 (1.24, 2.48) 1.77 (1.25, 2.50)
Native American
No ECG abnormality 100 (38.2) 1,0 1.0
ECG abnormality
Lowest (<2.3%) 23 (64.7) 1.47 (0.96, 2.24) 1.45 (0.93, 2.27)
2nd-4th (2.3%-9.3%) 196 (73.9) 1.78 (1.34, 2.38) 1.74 (1.29, 2.33)
Highest (9.4%) 58 (81.8) 1.96 (1.43, 2.68) 1.91 (1.40, 2.62)
European
No ECG abnormality 100 (38.8) 1.0 1.0
ECG abnormality
Lowest (<71%) 58 (79.9) 1.90 (1.37, 2.63) 1.90 (1.37, 2.63)
2nd-4th (71%-92.7%) 116 (72.0) 1.82 (1.39, 2.39) 1.76 (1.33, 2.32)
Highest (93%) 23 (77.2) 1.40 (0.89, 2.22) 1.37 (0.86, 2.17)
ECG, electrocardiogram; pyrs, person-years at risk; HR (95% CI), hazard ratio (95% confidence interval) estimated by Cox proportional hazards
regression.
aSmoking, body mass index, hypertension, diabetes, coronary heart disease, log high sensitivity C-reactive protein and non-HDL cholesterol plus cluster
in family.
bSchooling level, monthly household income per capita and father’s occupation.
doi:10.1371/journal.pntd.0004724.t005
Table 6. Association between individual proportion of Western African sub-continental genomic ancestry levels relative to total African ancestry
with Trypanosoma cruzi infection and anymajor electrocardiogram abnormalities among infected (The Bambui-Epigen Cohort Study of Aging).
Proportion of genomic Western African ancestrya in quintiles Infected with T. cruzi Any major ECG abnormality among
infected with T. cruzi
No. (%) Adjusted PR (95% CI)b No. (%) Adjusted PR (95% CI)b
Lowest (<33.3%) 79 (29.4) 1.0 49 (62.0) 1.0
2nd-4th (33.3%-73.3%) 327 (40.6) 0.97 (0.79, 1.19) 187 (57.2) 0.88 (0.70, 1.10)
Highest (73.3%) 99 (36.9) 0.99 (0.78, 1.26) 49 (49.5) 0.80 (0.58, 1.09)
p = 0.004 p = 0.221
ECG, electrocardiogram; PR (95% CI), prevalence ratio (95% confidence interval) estimated by Poisson regression; p, p value—Pearson´s chi square
test.
aRelative to total genomic African ancestry.
bAge, sex, smoking, body mass index, hypertension, diabetes, coronary heart disease, log high sensitivity C-reactive protein and non HDL cholesterol,
schooling level, monthly household income per capita and father’s occupation plus cluster in family.
doi:10.1371/journal.pntd.0004724.t006
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discrimination, and to report worse health outcomes [14,35]. Native Americans experience
sustained marginalization [36]. Our results are in agreement with these observations, revealing
higher levels of African and Native American ancestry in those with lower schooling and family
income levels, as well as those whose fathers were rural workers or had an unknown occupation
(which suggests a less prestigious occupational category). T. cruzi infection followed this trend,
with higher prevalence associated with worse current (measured by income) and worse early
socioeconomic circumstances (educational attainment and father’s occupation). However, the
association between higher levels of African and Native American ancestry with T. cruzi infec-
tion was attenuated, but still remained largely significant after adjustments for socioeconomic
indicators, suggesting a possible independent effect of genomic ancestry. Despite this finding,
it is important to emphasize that although we control for several important measures of current
and early socioeconomic circumstances, they cannot completely account for the complexity of
unfavorable trajectories of persons with higher levels of African and Native American ancestry
in Brazilian society [14]. Thus, we cannot exclude the possibility that residual confounding
may still account for the association between higher levels of African and Native American
ancestry and prevalent T. cruzi infection in our analysis. The fact that analyses of subsequent
complications (cardiomyopathy) showed no association with genomic ancestry further tem-
pers any inference regarding a causal relationship between genetic ancestry and increased vul-
nerability to T. cruzi.
Chronic Chagas cardiomyopathy is the most clinically relevant manifestation of the disease.
It manifests as heart failure, arrhythmia, heart block, thromboembolism, stroke and sudden
death [7,16]. The pathogenesis of chronic chagasic cardiomyopathy is not completely under-
stood [37], but inflammation caused by persistent parasitism of the heart tissue appears to play
an important role [38,39]. Additionally, a recent genome-wide study (GWAS) identified sug-
gestive single nucleotide polymorphisms (SNPs) that may impact the risk of progression to car-
diomyopathy in seropositive persons [37]. Electrocardiography has been considered an
important tool in the management of ChD patients [7]. Information on ECG findings among
the elderly infected with ChD is scant, and very few studies in middle-aged or older adults have
used core-lab readings using classifications developed by the internationally accepted Minne-
sota Code [8]. A previous study in the Bambui cohort showed that any major ECG abnormality
(classified by the Minnesota Code) was strongly and independently associated with increased
risk for 10-year mortality among T. cruzi infected older adults [8]. The results of the current
analysis, based on an extended 15 year-follow-up, are in agreement with these findings. Addi-
tionally, we found no evidence of an association between African and Native American ances-
tries and major ECG abnormalities among T. cruzi infected persons. The absence of an
association was consistent in bivariate analyses as well as those adjusted for an array of poten-
tial confounding factors. Furthermore, African, Native American and European ancestry
showed no significant interactions affecting the ability of major ECG abnormalities to predict
subsequent mortality.
Strengths of this study include the large population-based cohort followed for an extended
period, and minimal loss of participants to follow-up. Another major strength is the use of
genome-wide measures of ancestry. Genomic ancestry does not change over time, while ethno-
racial self-classification is prone to misclassification—particularly in admixed populations
[14,19]. Another strength is the inclusion of several biological and non-biological risk factors
in our analysis. However, one cannot exclude the possibility that there may be additional
unmeasured factors, including unknown genetic factors that confound our results.
The current study is, to our knowledge, the first investigation on the influence of African,
Native American and European genomic ancestry on T. cruzi infection and related outcomes.
Our findings indicate that African and Native American ancestry have no influence on the
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presence of major ECG abnormalities and had no influence on the ability of an ECG abnormal-
ity in predicting mortality in older people infected with T. cruzi. In contrast, our results
revealed a strong positive association between prevalent T. cruzi infection with higher levels of
African and Native American ancestry. Whether this association is a consequence of genetic
background, differential exposure to infection, or a combination of both factors, remains to be
determined.
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